International Carotid Stenting Study
investigators, EderleJDobsonJ, Carotid artery stenting compared with
endarterectomy in patients with symptomatic carotid stenosis (International
Carotid Stenting Study): an interim analysis of a randomized controlled
trial. Lancet.
2010;375:985–997.
2.
BonatiLHJongenLMHallerS., for the ICSS-MRI study group. New
ischaemic brain lesions on MRI after stenting or endarterectomy for
symptomatic carotid stenosis: a sub study of the International Carotid
Stenting Study (ICSS). Lancet Neurol.
2010;9:353–362.
3.
PiniRFaggioliGFittipaldiS. Inflammatory mediators and cerebral
embolism in carotid stenting: new markers of risk. J
Endovasc Ther.
2013;20:684–694.
4.
van
LammerenGWden HartogAGPasterkampG. Asymptomatic carotid artery stenosis:
identification of subgroups with different underlying plaque
characteristics. Eur J Vasc Endovasc Surg.
2012;43:632–636.
5.
RantnerBGoebelGBonatiLH.; Carotid Stenting Trialists'
Collaboration. The risk of carotid artery stenting compared with carotid
endarterectomy is greatest in patients treated within 7 days of
symptoms. J Vasc Surg.
2013;57:619–626.e2;.
6.
den
HartogAGBovensSMKoningW. PLACD-7T Study: Atherosclerotic
carotid plaque components correlated with cerebral damage at 7 Tesla
magnetic resonance imaging. Curr Cardiol
Rev.
2011;7:28–34.
7.
KingAMarkusHS.
Doppler embolic signals in cerebrovascular disease and
prediction of stroke risk. A systematic review and
meta-analysis. Stroke.
2009;40:3711–3717.
8.
de
BorstGJHilgevoordAAde VriesJP. Influence of antiplatelet therapy on
cerebral micro-emboli after carotid endarterectomy using postoperative
transcranial Doppler monitoring. Eur J Vasc Endovasc
Surg.
2007;34:135–142.
9.
GensickeHZumbrunnTJongenLM.; ICSS-MRI Substudy Investigators.
Characteristics of ischemic brain lesions after stenting or endarterectomy
for symptomatic carotid artery stenosis: results from the international
carotid stenting study-magnetic resonance imaging substudy.
Stroke.
2013;44:80–86.
10.
Alvarez
GarciaBRuizCChaconP. High-sensitivity C-reactive protein
in high-grade carotid stenosis: risk marker for unstable carotid
plaque. J Vasc Surg.
2003;38:1018–1024.
11.
PeetersWMollFLVinkA. Collagenase matrix
metalloproteinase-8 expressed in atherosclerotic carotid plaques is
associated with systemic cardiovascular outcome. Eur
Heart J.
2011;32:2314–2325.
12.
IonitaMGVinkADijkeIE. High levels of myeloid-related
protein 14 in human atherosclerotic plaques correlate with the
characteristics of rupture-prone lesions.
Arterioscler Thromb Vasc Biol.
2009;29:1220–1227.
13.
GröschelKErnemannULarsenJ. Preprocedural C-reactive protein
levels predict stroke and death in patients undergoing carotid
stenting. AJNR Am J Neuroradiol.
2007;28:1743–1746.
14.
SchillingerMExnerMMlekuschW. Inflammation and Carotid Artery-Risk
for Atherosclerosis Study (ICARAS).
Circulation.
2005;111:2203–2209.
15.
MalikRKLandisGSSundickS. Predicting embolic potential during
carotid angioplasty and stenting: analysis of captured particulate debris,
ultrasound characteristics, and prior carotid
endarterectomy. J Vasc Surg.
2010;51:317–322.
FreedmanJELoscalzoJ.
Platelet-monocyte aggregates. Bridging thrombosis and
inflammation. Circulation.
2002;105:2130–2132.
18.
HallerSAdlakhaSReedG. Platelet activation in patients with
atherosclerotic renal artery stenosis undergoing stent
revascularization. Clin J Am Soc Nephrol.
2011;6:2185–2191.
19.
BallaJMagyarMTBereczkiD. Serum levels of platelet released
CD40 ligand are increased in early onset occlusive carotid artery
disease. Dis Markers.
2006;22:133–140.
